BiotechTube
ASSAY Clinical Research

ASSAY Clinical Research

London, United Kingdom· Est.
assaycr.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ASSAY Clinical Research is a specialized, technology-enabled clinical research organization (CRO) offering end-to-end trial management and strategic resourcing services. Founded in 2012 and based in London, it distinguishes itself through a tailored approach, integrated electronic systems (e-TMF, e-ISF), and operational expertise in challenging regions like West Africa. The company serves as a service provider to the broader biopharma industry, focusing on efficient trial execution rather than developing its own therapeutic assets.

OncologyInfectious Diseases

Technology Platform

Integrated electronic Trial Master File (e-TMF) and Investigator Site File (e-ISF), Clinical Trial Management System (CTMS), and e-feasibility platform for site selection. Focus on tailored, intuitive technology solutions for clinical trial management.

Opportunities

Growing demand for clinical trial outsourcing, especially for complex trials in oncology and rare diseases.
Expansion into emerging clinical research regions like West Africa offers a first-mover advantage in accessing diverse patient populations.
The industry-wide shift towards digital trial solutions creates demand for its integrated e-TMF/e-ISF and CTMS services.

Risk Factors

Intense competition from large global CROs and other niche players.
Operational and reputational risk from potential failures in managing complex, high-stakes client trials.
Revenue vulnerability due to project-based business model and dependence on biopharma R&D spending cycles.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against giants like IQVIA, ICON, and Parexel, as well as numerous small-to-midsize specialist CROs. Differentiates through a tailored, high-touch service model, specific geographic expertise (West Africa), and a focus on integrating technology for complex Phase I-IV trials, particularly in oncology.

More companies in Digital Health & Biotech SaaS →More companies in United Kingdom →